Publication Date:
2013-03-01
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Ledford, Heidi -- England -- Nature. 2013 Feb 28;494(7438):410-1. doi: 10.1038/494410a.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/23446392" target="_blank"〉PubMed〈/a〉
Keywords:
Cholesterol, LDL/biosynthesis/*blood
;
Coronary Artery Disease/blood/prevention & control
;
Drug Industry
;
Evidence-Based Medicine/trends
;
Heart Arrest/blood/prevention & control
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology/therapeutic use
;
Male
;
National Heart, Lung, and Blood Institute (U.S.)
;
*Practice Guidelines as Topic
;
Proprotein Convertases/antagonists & inhibitors
;
Risk Factors
;
Serine Endopeptidases
;
Stroke/blood/prevention & control
;
United States
Print ISSN:
0028-0836
Electronic ISSN:
1476-4687
Topics:
Biology
,
Chemistry and Pharmacology
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink